TrialFrontiers in immunology2022

Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial.

Céline Grégoire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.